In contrast, APOC2 is a cofactor of LPL and its loss of function results in deficient LPL activity and consequent hypertriglyceridemia and chylomicronemia (Breckenridge et al., 1978; Cox et al., 1978). This evidence concerns the gene APOC2 and hypertriglyceridemia.